This is an old revision of this page, as edited by The chemistds (talk | contribs) at 00:18, 10 November 2011 (added CSID, (Std)InChI & (Std)InChIKey). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 00:18, 10 November 2011 by The chemistds (talk | contribs) (added CSID, (Std)InChI & (Std)InChIKey)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Identifiers | |
---|---|
CAS Number | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider | |
PubChem CID | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C12H12N2O3 |
Molar mass | 232.2 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references |
Dazoxiben is an orally active thromboxane synthase inhibitor. It has shown a significant clinical improvement in patients with Raynaud's syndrome.
References
- Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6337601, please use {{cite journal}} with
|pmid=6337601
instead. - Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6337601, please use {{cite journal}} with
|pmid=6337601
instead.
Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antiplatelet drugs |
| ||||||||||||||
Anticoagulants |
| ||||||||||||||
Thrombolytic drugs/ fibrinolytics | |||||||||||||||
Non-medicinal | |||||||||||||||
|